Transplant Infectious Disease

Papers
(The median citation count of Transplant Infectious Disease is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Clinical effectiveness of COVID‐19 vaccination in solid organ transplant recipients81
Threatening drug‐drug interaction in a kidney transplant patient with coronavirus disease 2019 (COVID‐19)51
Mucormycosis associated with COVID‐19 in two kidney transplant patients48
Treatment of recurrent urinary tract infections in a 60‐year‐old kidney transplant recipient. The use of phage therapy42
Outcomes of COVID‐19 in solid organ transplant recipients: A matched cohort study41
Organ recovery from deceased donors with prior COVID‐19: A case series40
Case report: A kidney transplant patient with mild COVID‐1939
COVID‐19 in solid organ transplant recipients: Dynamics of disease progression and inflammatory markers in ICU and non‐ICU admitted patients39
COVID‐19 in kidney transplant recipients: A multicenter experience in Istanbul38
COVID‐19 in solid organ transplant recipients: No difference in survival compared to general population36
COVID‐19 in lung transplant recipients34
COVID‐19 in recent heart transplant recipients: Clinicopathologic features and early outcomes33
Monoclonal antibody treatment for COVID‐19 in solid organ transplant recipients33
Treatment of immunocompromised COVID‐19 patients with convalescent plasma33
Letermovir treatment of cytomegalovirus infection or disease in solid organ and hematopoietic cell transplant recipients32
Epidemiology, risk factors, and outcomes associated with cytomegalovirus in adult kidney transplant recipients: A systematic literature review of real‐world evidence30
COVID‐19 in an HIV‐positive kidney transplant recipient30
COVID‐19 pneumonia in kidney transplant recipients: Focus on immunosuppression management30
Mucormycosis in post‐COVID‐19 renal transplant patients: A lethal complication in follow‐up30
Viruses, friends, and foes: The case of Torque Teno Virus and the net state of immunosuppression29
SARS‐CoV2 and immunosuppression: A double‐edged sword29
Case series of six kidney transplanted patients with COVID‐19 pneumonia treated with tocilizumab29
Impact of COVID‐19 in hematopoietic stem cell transplant recipients: A systematic review and meta‐analysis28
Outcomes of bebtelovimab and sotrovimab treatment of solid organ transplant recipients with mild‐to‐moderate coronavirus disease 2019 during the Omicron epoch26
Outcome of COVID‐19 in liver transplant recipients: A preliminary report from Northwestern Italy25
An International survey on living kidney donation and transplant practices during the COVID‐19 pandemic25
The alteration of the gut microbiome by immunosuppressive agents used in solid organ transplantation24
The pandemic provides a pathway: What we know and what we need to know about using COVID positive donors24
A case of successful treatment of severe COVID‐19 pneumonia with favipiravir and tocilizumab in post–kidney transplant recipient24
Successful recovery from severe COVID‐19 pneumonia after kidney transplantation: The interplay between immunosuppression and novel therapy including tocilizumab24
Antibody response to two doses of inactivated SARS‐CoV‐2 vaccine (CoronaVac) in kidney transplant recipients24
Outpatient management of kidney transplant recipients with suspected COVID‐19—Single‐center experience during the New York City surge24
Iranian kidney transplant recipients with COVID‐19 infection: Clinical outcomes and cytomegalovirus coinfection24
Feasibility and safety of remdesivir in SARS‐CoV2 infected renal transplant recipients: A retrospective cohort from a developing nation22
Hepatitis C‐positive donor to negative recipient kidney transplantation: A real‐world experience22
Invasive pulmonary aspergillosis associated with COVID‐19 in a kidney transplant recipient21
COVID‐19 and kidney transplant recipients21
SARS‐CoV‐2 infection in kidney transplant recipients: Experience of the italian marche region21
Humoral and cellular immune responses to the SARS‐CoV‐2 BNT162b2 vaccine among a cohort of solid organ transplant recipients and healthy controls21
Initial experience of bamlanivimab monotherapy use in solid organ transplant recipients21
Emergence of letermovir resistance in solid organ transplant recipients with ganciclovir resistant cytomegalovirus infection: A case series and review of the literature21
Clinical presentation and outcomes of COVID‐19 following hematopoietic cell transplantation and cellular therapy21
Severe COVID‐19 in a patient with chronic graft‐versus‐host disease after hematopoietic stem cell transplant successfully treated with ruxolitinib20
Letermovir prophylaxis in solid organ transplant—Assessing CMV breakthrough and tacrolimus drug interaction20
Outcome according to subspecies following lung transplantation in cystic fibrosis pediatric patients infected with Mycobacterium abscessus20
Coronavirus disease 2019 vaccination is protective of clinical disease in solid organ transplant recipients20
Treatment of invasive IMP‐4Enterobacter cloacaeinfection in transplant recipients using ceftazidime/avibactam with aztreonam: A case series and literature review20
COVID‐19 and liver transplantation: Lessons learned from three reported cases19
Breakthrough COVID‐19 after SARS‐CoV‐2 vaccination in solid organ transplant recipients: An analysis of symptomatic cases and monoclonal antibody therapy19
Successful liver transplantation in a patient recovered from COVID‐1919
Kidney transplantation from a SARS‐CoV‐2‐positive donor for the recipients with immunity after COVID‐1919
Interleukin‐6 receptor antagonist therapy to treat SARS‐CoV‐2 driven inflammatory syndrome in a kidney transplant recipient18
Successful heart and kidney transplantation from a deceased donor with PCR positive COVID‐1918
Detection of adenovirus hepatitis and acute liver failure in allogeneic hematopoietic stem cell transplant patients18
Short‐term liver transplant outcomes from SARS‐CoV‐2 lower respiratory tract NAT positive donors18
COVID‐19 in lung transplant recipients: A case series from Milan, Italy18
Transplant of organs from donors with positive SARS‐CoV‐2 nucleic acid testing: A report from the organ procurement and transplantation network ad hoc disease transmission advisory committee17
Absolute lymphocyte count as marker of cytomegalovirus and allograft rejection: Is there a “Safe Corridor” after kidney transplantation?17
Early experience with SARs‐CoV‐2 mRNA vaccine breakthrough among kidney transplant recipients17
COVID‐19 pneumonia in kidney transplant recipients—Where we are?17
Outcomes of transplant recipients treated with cidofovir for resistant or refractory cytomegalovirus infection17
Varied clinical presentation and outcome of SARS‐CoV‐2 infection in liver transplant recipients: Initial experience at a single center in Madrid, Spain17
Commercial insurance delays direct‐acting antiviral treatment for hepatitis C kidney transplantation into uninfected recipients16
COVID‐19 clinical manifestations and treatment strategies among solid‐organ recipients: A systematic review of cases16
Humoral and cellular response of COVID‐19 vaccine among solid organ transplant recipients: A systematic review and meta‐analysis16
COVID‐19 infection in solid organ transplant recipients: A single‐center experience with patients immediately after transplantation16
Successful recovery from COVID‐19 in three kidney transplant recipients who received convalescent plasma therapy16
A case report of successful kidney transplantation from a deceased donor with terminal COVID‐19‐related lung damage: Ongoing dilemma between discarding and accepting organs in COVID‐19 era!16
Antifungal prophylaxis in lung transplant recipients: A systematic review and meta‐analysis16
Zoonotic sporotrichosis in renal transplant recipients from Rio de Janeiro, Brazil16
Impact of donor multidrug‐resistant organisms on solid organ transplant recipient outcomes16
Failed antibody response in a renal transplant recipient with SARS‐CoV‐2 infected15
Effect of immunosuppression maintenance in solid organ transplant recipients with COVID‐19: Systematic review and meta‐analysis15
A retrospective matched cohort single‐center study evaluating outcomes of COVID‐19 and the impact of immunomodulation on COVID‐19‐related cytokine release syndrome in solid organ transplant recipients15
Epidemiology and risk factors for invasive fungal disease in liver transplant recipients in a tertiary transplant center15
Cytomegalovirus antiviral stewardship in solid organ transplant recipients: A new gold standard15
Is the Omicron variant truly less virulent in solid organ transplant recipients?15
Eosinophilic gastroenteritis and graft‐versus‐host disease induced by transmission of Norovirus with fecal microbiota transplant14
Solid organ transplantation from COVID positive donors in the United States: Analysis of United Network for Organ Sharing database14
Isavuconazole for the prophylaxis and treatment of invasive fungal disease: A single‐center experience14
Risk factors of BK viral hemorrhagic cystitis in allogenic hematopoietic stem cell transplantation14
Influence of immunosuppression on seroconversion against SARS‐CoV‐2 in two kidney transplant recipients14
Clinical characteristics of COVID‐19 in solid organ transplant recipients following COVID‐19 vaccination: A multicenter case series14
Long‐term follow‐up of SARS‐CoV‐2 recovered renal transplant recipients: A single‐center experience from India14
Cytomegalovirus in the transplant setting: Where are we now and what happens next? A report from the International CMV Symposium 202114
American trypanosomiasis (Chagas disease) in solid organ transplantation14
Pregnancy after CMV infection following uterus transplantation: A case report from the Dallas Uterus Transplant Study14
Coronavirus disease 2019 in renal transplant recipients: Report of two cases13
Coinfection rates and clinical outcome data for cytomegalovirus and Epstein‐Barr virus in post‐transplant patients: A systematic review of the literature13
COVID‐19 in a lung transplant recipient: Exploring the diagnostic role of circulating exosomes and the clinical impact of advanced immunosuppression13
Post‐infection pulmonary sequelae after COVID‐19 among patients with lung transplantation13
Evaluation of Quantiferon®‐Monitor as a biomarker of immunosuppression and predictor of infection in lung transplant recipients13
Heart and liver transplant recipients from donor with positive SARS‐CoV‐2 RT‐PCR at time of transplantation13
Liver transplant recipients infected with SARS‐CoV‐2 in the early postoperative period: Lessons from a single center in the epicenter of the pandemic13
Assessment of infectious complications in elderly kidney transplant recipients receiving induction with anti‐thymocyte globulin vs basiliximab12
The addition of adjunctive letermovir to valganciclovir for refractory cytomegalovirus viremia in kidney transplant recipients12
Is it safe to perform abdominal transplantation from SARS‐CoV‐2 polymerase chain reaction positive donors?12
Cell‐free next‐generation sequencing impacts diagnosis and antimicrobial therapy in immunocompromised hosts: A retrospective study12
Nocardia prophylaxis, treatment, and outcomes of infection in lung transplant recipients: A matched case‐control study12
Simultaneous coccidioidomycosis and phaeohyphomycosis in a kidney transplant recipient: A case report and literature review12
Kidney transplantation during coronavirus 2019 pandemic at a large hospital in Miami12
Coronavirus disease 2019 in an orthotopic liver transplant recipient living with human immunodeficiency virus12
Kidney transplant recipients infected by COVID‐19: Review of the initial published experience11
Assessment of humoral and cellular immune responses to SARS CoV‐2 vaccination (BNT162b2) in immunocompromised renal allograft recipients11
Hyperammonemia syndrome due to Ureaplasma infection after liver‐kidney transplant11
Sources and prevention of graft infection during long‐term ex situ liver perfusion11
Drug‐resistant organisms are common in fecal surveillance cultures, predict bacteremia and correlate with poorer outcomes in patients undergoing allogeneic stem cell transplants11
Successful treatment of Aspergillus fumigatus sternal osteomyelitis with isavuconazole in a heart transplant recipient11
Clinical characteristics and outcomes of toxoplasmosis among transplant recipients at two US academic medical centers11
Antifungal stewardship in solid organ transplantation11
Extended letermovir administration, beyond day 100, is effective for CMV prophylaxis in patients with graft versus host disease11
Respiratory syncytial virus and human metapneumovirus after allogeneic hematopoietic stem cell transplantation: Impact of the immunodeficiency scoring index, viral load, and ribavirin treatment on the11
Letermovir conversion after valganciclovir treatment in cytomegalovirus high‐risk abdominal solid organ transplant recipients may promote development of cytomegalovirus‐specific cell mediated immunity11
Scedosporium apiospermum and Lomentospora prolificans in lung transplant patients – A single center experience over 24 years11
Immune reconstitution and severity of COVID‐19 among hematopoietic cell transplant recipients11
Phage therapy in a lung transplant recipient with cystic fibrosis infected with multidrug‐resistant Burkholderia multivorans11
T‐cell adoptive immunotherapy for BK nephropathy in renal transplantation10
A randomized, controlled trial comparing the immunogenecity and safety of a 23‐valent pneumococcal polysaccharide vaccination to a repeated dose 13‐valent pneumococcal conjugate vaccination in kidney 10
The role of 18F‐Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG PET/CT) in assessment of complex invasive fungal disease and opportunistic co‐infections in patients with acute10
Incidence of herpes zoster in adult solid organ transplant recipients: A meta‐analysis and comprehensive review10
Risk factors and outcomes of COVID associated mucormycosis in kidney transplant recipients10
Effects of intravenous immunoglobulin therapy and Fc gamma receptor polymorphisms on BK virus nephropathy in kidney transplant recipients10
Rapid molecular detection of airway pathogens in lung transplant recipients10
The importance of uninterrupted albendazole treatment in patients with unresectable alveolar echinococcosis undergoing liver transplantation10
The outcomes of Clostridioides difficile infection in inpatient liver transplant population10
Short‐term kidney transplant outcomes from severe acute respiratory syndrome coronavirus 2 lower respiratory tract positive donors10
Microbiologically documented infections after adult allogeneic hematopoietic cell transplantation: A 5‐year analysis within the Swiss Transplant Cohort study10
Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study10
Clinical characteristics and outcome of COVID‐19 pneumonia in kidney transplant recipients in Razi hospital, Rasht, Iran10
Polymyxin B‐induced skin hyperpigmentation10
Prediction of cytomegalovirus infection: A single‐center experience utilizing a newly available cell‐mediated immunity assay by flow cytometry, a risk factor screening tool, and serologically demonstr10
Recent developments in trichodysplasia spinulosa disease10
Kidney transplant recipients’ attitudes toward COVID‐19 vaccination and barriers and enablers to vaccine acceptance10
Post‐transplant survey to assess patient experiences with donor‐derived HCV infection9
Hyperammonemia syndrome due to Ureaplasma urealyticum in a kidney transplant recipient: A case of disseminated disease from a fluoroquinolone‐resistant isolate9
SARS‐CoV‐2 infection after two doses of mRNA vaccine in renal transplant recipients9
Diagnosis of central nervous system invasive aspergillosis in a liver transplant recipient using microbial cell‐free next generation DNA sequencing9
Matched retrospective study of infective endocarditis among solid organ transplant recipients compared to non‐transplant: Seven‐year experience in a US Referral Center9
Efficacy and safety of chronic antimicrobial suppression therapy for left ventricular assist device driveline infections: A single‐center descriptive experience9
De novo emergence of SARS‐CoV‐2 spike mutations in immunosuppressed patients9
Low rate of COVID‐19 pneumonia in kidney transplant recipients—A battle between infection and immune response?9
Isolated pulmonary fusariosis caused by Neocosmospora pseudensiformis in a liver transplant recipient: A case report and review of the literature9
Successful management of noncirrhotic hyperammonemia syndrome after kidney transplantation from putative Ureaplasma infection9
Hyponatremia: A possible immuno‐neuroendocrine interface with COVID‐19 in a kidney transplant recipient9
Characteristics and outcomes among vaccinated lung transplant patients with breakthrough COVID‐199
Epidemiology, management, and graft outcomes after West Nile virus encephalitis in kidney transplant recipients9
Universal molecular Clostridioides difficile screening and overtreatment in solid organ transplant recipients9
Practice patterns and incidence of adenovirus infection in allogeneic hematopoietic cell transplant recipients: Multicenter survey of transplant centers in the United States9
The coverage of influenza and pneumococcal vaccination among kidney transplant recipients and waiting list patients: A cross‐sectional survey in Denmark9
Bronchial anastomosis dehiscence and stenosis caused by donor‐transmitted Mycoplasma hominis infection in a lung transplant recipient: Case report and literature review9
Infections after kidney transplantation: A comparison of mTOR‐Is and CNIs as basic immunosuppressants. A systematic review and meta‐analysis9
COVID‐19 in pancreas transplant recipients9
Evaluation of targeted versus universal prophylaxis for the prevention of invasive fungal infections following lung transplantation9
Reinfection with SARS‐CoV‐2 in solid‐organ transplant recipients: Incidence density and convalescent immunity prior to reinfection9
A pragmatic outreach pilot to understand and overcome barriers to COVID‐19 vaccination in abdominal organ transplant9
SARS‐CoV‐2 infection in kidney transplant recipients: Early report of five cases9
Antibody response to mRNA SARS‐CoV‐2 vaccination in 182 patients after allogeneic hematopoietic cell transplantation9
Incidence, etiology, risk factors, and outcomes of pre‐engraftment bloodstream infections after first and second allogeneic hematopoietic cell transplantation9
Cytomegalovirus events in high‐risk allogeneic hematopoietic‐cell transplantation patients who received letermovir prophylaxis8
Recurrent nocardiosis in solid organ transplant recipients: An evaluation of secondary prophylaxis8
Incidental COVID‐19 in a heart‐kidney transplant recipient with malnutrition and recurrent infections: Implications for the SARS‐CoV‐2 immune response8
Impact of solid organ transplant status on outcomes of hospitalized patients with COVID‐19 infection8
Daptomycin perioperative prophylaxis for the prevention of vancomycin‐resistant Enterococcus infection in colonized liver transplant recipients8
Adoptive transfer of ex vivo expanded SARS‐CoV‐2‐specific cytotoxic lymphocytes: A viable strategy for COVID‐19 immunosuppressed patients?8
Decreasing voriconazole requirement in a patient after extracorporeal membrane oxygenation discontinuation: A case report8
Efficacy of β‐lactam/β‐lactamase inhibitors to treat extended‐spectrum beta‐lactamase‐producing Enterobacterales bacteremia secondary to urinary tract infection in kidney transplant recipients 8
A case series of multidrug‐resistant tuberculosis in renal transplant recipients: Challenges in management from a TB endemic country8
Treatment of asymptomatic bacteriuria in the first 2 months after kidney transplant: A controlled clinical trial8
Cytomegalovirus antiviral stewardship in the COVID‐19 Era: Increasing complexity of prophylaxis and treatment and potential mitigation strategies8
Early Clostridioides difficile infection characterizations, risks, and outcomes in allogeneic hematopoietic stem cell and solid organ transplant recipients8
COVID‐19 in lung transplant recipients: A single‐center experience8
Baloxavir for the treatment of Influenza in allogeneic hematopoietic stem cell transplant recipients previously treated with oseltamivir8
The hamletic dilemma of patients waiting for kidney transplantation during the COVID‐19 pandemic: To accept or not to accept (an organ offer)?8
Epidemiology of candidemia in lung transplant recipients and risk factors for candidemia in the early posttransplant period in the absence of universal antifungal prophylaxis8
Baloxavir treatment of oseltamivir‐resistant influenza A/H1pdm09 in two immunocompromised patients8
Infectious disease consultation is effective in boosting vaccine coverage in patients awaiting kidney transplantation: A French prospective study8
Clearance of longstanding treatment‐resistant warts during COVID‐19 in a transplant recipient7
Trimethoprim/sulfamethoxazole for nocardiosis in solid organ transplant recipients: Real‐life data from a multicentre retrospective study7
SARS‐CoV‐2 vaccine clinical efficacy in SOT: What we know and our current gaps7
Management of transplant patients outside hospital during COVID‐19 epidemic: A Chinese experience7
Development and longevity of antibodies against SARS‐CoV‐2 in kidney transplant recipients after symptomatic COVID‐197
Trichodysplasia spinulosa: Case reports and review of literature7
Utilization of hepatitis C viremic donors for liver transplant recipients without hepatitis C. A veterans transplant center report7
Bacterial genotype and clinical outcomes in solid organ transplant recipients with Staphylococcus aureus bacteremia7
Donor derived hepatitis B virus infection: Analysis of the Organ Procurement & Transplantation Network/United Network for Organ Sharing Ad Hoc Disease Transmission Advisory Committee7
Incidence of breakthrough fungal infections on isavuconazole prophylaxis compared to posaconazole and voriconazole7
Risk factors and clinical outcomes of tuberculosis among kidney transplant recipients in high endemic country7
Cytomegalovirus (CMV) management in allogeneic hematopoietic cell transplantation: Pre‐transplant predictors of survival, reactivation, and spontaneous clearance7
Real‐world effectiveness of preemptive therapy (PET) for cytomegalovirus (CMV) disease prevention in CMV high‐risk donor seropositive/recipient seronegative (D+R‐) liver transplant recipients (LTxR)7
Moving xenotransplantation from bench to bedside: Managing infectious risk7
COVID‐19, liver transplant, and immunosuppression: Allies or foes?7
Moderate acceptance of COVID‐19 vaccination in patients pre‐ and post‐heart transplantation: Experiences from a German Transplant Centre7
Early steps to kidney transplantation among persons with HIV and end‐stage renal disease in ESRD network 67
Cytomegalovirus myocarditis in solid organ transplant recipients: A case series and review of literature7
Extending cytomegalovirus prophylaxis in high‐risk (D+/R−) lung transplant recipients from 6 to 9 months reduces cytomegalovirus disease: A retrospective study7
Assessment of immunodeficiency scoring index performance in enterovirus/rhinovirus respiratory infection after allogeneic hematopoietic stem cell transplantation7
Risk factor analysis for cytomegalovirus reactivation under prophylaxis with letermovir after allogeneic hematopoietic stem cell transplantation7
Are Clostridioides difficile infections being overdiagnosed in hematopoietic stem cell transplant recipients?7
Donor‐derived tuberculosis among solid organ transplant recipients in the United States—2008 to 20187
Incidence rate of active tuberculosis in solid organ transplant recipients: Data from a nationwide population cohort in a high‐endemic country7
Successful implementation of preventive measures leads to low relevance of SARS‐CoV‐2 in liver transplant patients: Observations from a German outpatient department7
Clinical decision making is improved by BioFire Pneumonia Plus in suspected lower respiratory tract infection after lung transplantation: Results of the prospective DBATE‐IT* study7
Perinephric abscess in a renal transplant recipient due to Mycoplasma hominis: Case report and review of the literature7
Heart transplant recipient patient with COVID‐19 treated with tocilizumab7
Inherited chromosomally integrated human herpesvirus‐6 in a patient with XIAP deficiency6
Clinical risk score for predicting invasive fungal disease after allogeneic hematopoietic stem cell transplantation: Analysis of the China Assessment of Antifungal Therapy in Hematological Diseases (C6
Hyperammonemia syndrome post‐lung transplantation: Case series and systematic review of literature6
A nosocomial scabies outbreak originating from immunocompromised transplant patients in Turkey: Upholstery as a possible cause6
Hepatitis B Immunoglobulin discontinuation in long‐term liver transplant patients6
Favorable outcomes of COVID‐19 in vaccinated hematopoietic stem cell transplant recipients: A single‐center experience6
Liver transplant evaluation for fulminant liver failure due to acute hepatitis A infection: Case series and literature review6
A split strategy to prevent cytomegalovirus after kidney transplantation using prophylaxis in serological high‐risk patients and a pre‐emptive strategy in intermediate‐risk patients: Combining the bes6
Impact of SARS‐CoV‐2 outbreak on heart and lung transplant: A patient‐perspective survey6
Retrospective case analysis of antiviral therapies for HHV‐6 encephalitis after hematopoietic stem cell transplantation6
Clinical course of human monkeypox infection in a renal transplant recipient living with human immunodeficiency virus6
Parvovirus B19 infection in pediatric allogeneic hematopoietic cell transplantation – Single‐center experience and review6
Kinetics of Torque Teno virus DNA in stools may predict occurrence of acute intestinal graft versus host disease early after allogeneic hematopoietic stem cell transplantation6
Alternative pneumocystis prophylaxis in solid organ transplant recipients at two large transplant centers6
Central nervous system infections in renal transplant recipients6
Disparities in vaccination rates in solid organ transplant patients6
Kinetics of torquetenovirus DNA load in a recent kidney transplant recipient with mild SARS‐CoV‐2 infection and a failed antibody response6
Secondary antibody deficiency is associated with development of infection in kidney transplantation: Results of a multicenter study6
Pyogenic liver abscess in liver transplant recipient: A warning signal for the risk of recurrence and retransplantation6
Fluoroquinolones for BK viral complication after transplantation: Meta‐analysis6
Post kidney transplant histoplasmosis: An under‐recognized diagnosis in India6
Blastomycosis in solid organ transplant recipients—A retrospective series from southeastern Wisconsin6
Lung transplant recipient attitudes and beliefs on accepting an organ that is positive for hepatitis C virus6
Transmission of malaria from donors to solid organ transplant recipients: A case report and literature review6
Talaromycosis in a renal transplant recipient returning from South China6
Effectiveness of short vs long‐course perioperative antibiotics in lung transplant recipients with donor positive respiratory cultures6
Antifungal prophylaxis in adult lung transplant recipients: Uncertainty despite 30 years of experience. A systematic review of the literature and network meta‐analysis6
COVID‐19 vaccination timing and kidney transplant waitlist management: An international perspective6
Antibiotic allergy labels in immunocompromised populations6
Gram‐negative bacteremia in solid organ transplant recipients: Clinical characteristics and outcomes as compared to immunocompetent non‐transplant recipients6
Secondary syphilis with liver involvement in a liver transplant recipient6
Risks and outcomes of adenovirus disease in pediatric hematopoietic stem cell transplant recipients—Comparison of current antiviral treatment options6
Detection of community‐acquired respiratory viruses in allogeneic stem‐cell transplant recipients and controls—A prospective cohort study6
The burden of cytomegalovirus infection remains high in high‐risk kidney transplant recipients despite six‐month valganciclovir prophylaxis6
Association between gut colonization of vancomycin‐resistant enterococci and liver transplant outcomes6
A case report of tigecycline induced acute pancreatitis in a renal transplant patient and review of the literature: Should we avoid tigecycline in patients on calcineurin inhibitors?6
Successful management of T‐cell mediated rejection in a recent kidney transplant recipient with COVID‐19 associated severe acute respiratory syndrome6
Hypothermic oxygenated machine‐perfusion fluid‐related infection in a liver transplant recipient: First case report in the literature6
Failure of multiplex meningitis/encephalitis (ME) NAT during cryptococcal meningitis in solid organ recipients6
Polyomavirus and cytomegalovirus infections are risk factors for grafts loss in simultaneous pancreas and kidney transplant6
Ecthyma gangrenosum without bacteremia in a 54‐year‐old woman with heart transplant6
Donor‐derived herpes simplex virus hepatitis in a kidney transplant recipient and review of the literature6
Cutaneous infection caused by paraconiothyrium cyclothyrioides in a renal transplant recipient5
Successful treatment of CMV, EBV, and adenovirus tissue infection following HLA‐mismatched allogeneic stem cell transplant using infusion of third‐party T cells from multiple donors in addition to ant5
Human herpesvirus 6 reactivation in unmanipulated haploidentical hematopoietic stem cell transplantation predicts the occurrence of grade II to IV acute graft‐versus‐host disease5
Early cytomegalovirus DNAemia and antiviral dose adjustment in high vs intermediate risk kidney transplant recipients5
0.056351900100708